Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-09-08

Clinical Trial Update: A Study of Baclofen ER [Phase 2]

View source ↗

Summary

A Phase 2 trial of Baclofen ER for cocaine dependence has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Baclofen ER (baclofen extended-release)

Snippet

Sponsor: University of Pennsylvania | Conditions: Cocaine Dependence | Phase 2 | Status: WITHDRAWN